MOBIX LABS, INC
Business
Mobix Labs designs, develops and sells components and systems for advanced wireless and wired connectivity, RF, switching and EMI filtering technologies used in defense, aerospace, commercial, industrial and healthcare markets. Products include wireless systems solutions for RF and mmWave communications, mmWave imaging, software-defined radio and custom RF ICs, plus interconnect products such as EMI filter inserts and filtered connectors. The company operates through internal development and strategic acquisitions (including EMI Solutions and RaGE Systems) to expand product portfolios and serve defense, aerospace, industrial and satellite communications segments globally.
Summary from 10-K filed 2026-01-13
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|
| Net revenue | 10 | 6 | — | — | |
| Cost of revenue | 5 | 4 | 2 | — | |
| Gross profit | 5 | 3 | −396,000 | — | |
| Research and development | 2 | 6 | 11 | — | |
| Selling, general and administrative | 40 | 42 | 24 | — | |
| Impairment of long-lived assets | 725,000 | 1 | — | — | |
| Loss from operations | −38 | −46 | −36 | −1 | |
| Interest expense | 2 | 2 | 3 | — | |
| Change in fair value of earnout liability | −440,000 | −32 | — | — | |
| Change in fair value of warrants | −804,000 | −1 | — | 1 | |
| Change in fair value of PIPE make-whole liability | — | −830,000 | — | — | |
| Merger-related transaction costs expensed | — | 4 | — | — | |
| Financing costs expensed | 7 | 3 | — | — | |
| Other non-operating losses, net | 84,000 | 2 | — | — | |
| Loss before income taxes | −46 | −22 | −40 | −776,129 | |
| Provision (benefit) for income taxes | 7,000 | −2 | 67,000 | 0 | |
| Net loss and comprehensive loss | −46 | −20 | −40 | −776,129 | |
| Deemed dividend from warrant price adjustment | — | 661,000 | — | — | |
| Net loss available to common stockholders | −46 | −21 | −40 | — | |
| Basic (per share) | −1.01 | −0.73 | −2.71 | — | |
| Diluted (per share) | −1.01 | −0.75 | −2.71 | — | |
| Basic (shares) | 45 | 28 | 15 | — | |
| Diluted (shares) | 45 | 29 | 15 | 5 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-12-31 | FY 2022 2022-09-30 |
|---|---|---|---|---|---|---|
| Cash | 3 | 266,000 | 89,000 | — | — | |
| Accounts receivable, net | 1 | 3 | 53,000 | — | — | |
| Inventory | 1 | 2 | 319,000 | — | — | |
| Prepaid expenses and other current assets | 593,000 | 467,000 | 369,000 | — | — | |
| Total current assets | 7 | 5 | 830,000 | 175,788 | — | |
| Property and equipment, net | 328,000 | 1 | 2 | — | — | |
| Intangible assets, net | 14 | 15 | 5 | — | — | |
| Goodwill | 16 | 16 | 5 | — | — | |
| Operating lease right-of-use assets | 370,000 | 1 | 1 | — | — | |
| Other assets | 115,000 | 341,000 | 400,000 | — | — | |
| Total assets | 37 | 39 | 19 | 10 | — | |
| Accounts payable | 9 | 11 | 9 | — | — | |
| Accrued expenses and other current liabilities | 11 | 10 | 5 | 358,257 | — | |
| Deferred purchase consideration | 2 | 2 | — | — | — | |
| Operating lease liabilities, current | 274,000 | 428,000 | 318,000 | — | — | |
| Total current liabilities | 28 | 26 | 20 | 1 | — | |
| Earnout liability | 1 | 2 | — | — | — | |
| Deferred tax liability | 321,000 | 320,000 | 86,000 | — | — | |
| Operating lease liabilities, noncurrent | 96,000 | 1 | 1 | — | — | |
| Liability-classified warrants | 7 | 2 | — | — | — | |
| Other noncurrent liabilities | 48,000 | 1 | — | — | — | |
| Total liabilities | 37 | 34 | 22 | 2 | — | |
| Commitments and contingencies (Note 13) | — | — | — | — | — | |
| Additional paid-in capital | 150 | 110 | 78 | 30 | — | |
| Accumulated deficit | −151 | −104 | −84 | −2 | — | |
| Total stockholders equity (deficit) | −336,000 | 6 | −5 | −2 | −9 | |
| Total liabilities and stockholders equity (deficit) | 37 | 39 | 19 | 10 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|
| Depreciation | 366,000 | 472,000 | 449,000 | — | |
| Amortization of intangible assets | 2 | 2 | 841,000 | — | |
| Issuance of warrants in connection with financing activities, charged to expense | 6 | 1 | 3 | — | |
| Private placement costs expensed | 280,000 | 3 | — | — | |
| Stock-based compensation | 26 | 21 | 15 | — | |
| Deferred income taxes | 1,000 | −2 | 66,000 | — | |
| Other non-cash items | 751,000 | 693,000 | −117,000 | — | |
| Accounts receivable | 1 | −2 | 385,000 | — | |
| Inventory | 290,000 | −105,000 | 251,000 | — | |
| Prepaid expenses and other assets | 11,000 | 60,000 | 298,000 | — | |
| Accounts payable | −1 | 4 | 1 | — | |
| Accrued expenses and other current liabilities | 922,000 | 3 | 2 | — | |
| Net cash used in operating activities | −10 | −18 | −15 | −321,008 | |
| Proceeds from sale of property and equipment | 27,000 | — | — | — | |
| Acquisition of property and equipment | −26,000 | −44,000 | — | — | |
| Acquisitions of businesses, net of cash acquired | — | −1 | −633,000 | — | |
| Net cash provided by (used in) investing activities | 1,000 | −1 | −633,000 | 70 | |
| Proceeds from sale of common stock and warrants in private placements | 4 | 4 | — | — | |
| Proceeds from issuance of common stock | 2 | 4 | 14 | — | |
| Proceeds from exercise of common stock warrants | 5 | 4,000 | 909,000 | — | |
| Proceeds from exercise of stock options | — | 225,000 | — | — | |
| Principal payments on notes payable | −1 | −2 | −825,000 | — | |
| Principal payments on notes payable related parties | −574,000 | −1 | −630,000 | — | |
| Deferred consideration paid for acquisitions of businesses | −174,000 | −174,000 | — | — | |
| Proceeds from the Merger and PIPE | — | 21 | — | — | |
| Merger-related transaction costs paid | — | −7 | −933,000 | — | |
| Net cash provided by financing activities | 13 | 20 | 15 | −70 | |
| Net increase in cash | 3 | 177,000 | −89,000 | — | |
| Cash paid for interest | 2 | 521,000 | 58,000 | — | |
| Cash paid for income taxes | — | — | — | — | |
| Settlement of notes payable and other liabilities in Class A Common Stock | 1 | — | — | — | |
| Class A Common Stock issued for RaGE earnout | 2 | — | — | — | |
| Unpaid Merger-related transaction costs | — | 1 | — | — | |
| Contingently redeemable convertible stock issued for acquisition of EMI Solutions, Inc. | — | 9 | — | — | |
| Class A Common Stock issued for acquisition of RaGE Systems, Inc. | — | 8 | — | — | |
| Deferred purchase consideration for acquisitions of businesses | — | 4 | — | — | |
| Conversion of SAFEs to common stock | — | 2 | — | — | |
| Deemed dividend from warrant price adjustment | — | 661,000 | — | — | |
| Issuance of warrants in connection with notes payable, recorded as debt discount | — | 183,000 | 790,000 | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is MOBIX LABS, INC's CIK number?
MOBIX LABS, INC's SEC CIK number is 0001855467 (1855467). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find MOBIX LABS, INC's SEC filings?
All of MOBIX LABS, INC's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did MOBIX LABS, INC last report earnings?
MOBIX LABS, INC (MOBX) most recently filed an earnings 8-K with the SEC on Dec 4, 2025, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001493152-25-026105). This is MOBIX LABS, INC's most recent earnings filing of record — not a forecast of its next earnings date.
What is MOBIX LABS, INC's most recent earnings 8-K?
MOBIX LABS, INC's latest earnings 8-K (Item 2.02) was filed Dec 4, 2025 under accession 0001493152-25-026105. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View MOBIX LABS, INC's latest earnings 8-K →
Look up any company's CIK number →